Jeetinder Singh Mahal - 12 Dec 2024 Form 4 Insider Report for Jasper Therapeutics, Inc. (JSPR)

Signature
By: /s/ Jeet Mahal
Issuer symbol
JSPR
Transactions as of
12 Dec 2024
Net transactions value
-$13,509
Form type
4
Filing time
12 Dec 2024, 20:02:41 UTC
Previous filing
12 Sep 2024
Next filing
18 Feb 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JSPR Voting Common Stock Options Exercise $6,390 +900 +3.6% $7.10 25,909 12 Dec 2024 Direct F1
transaction JSPR Voting Common Stock Sale $19,899 -900 -3.5% $22.11 25,009 12 Dec 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JSPR Stock Option (right to buy) Options Exercise $0 +900 +7% $0.000000 13,772 12 Dec 2024 Voting Common Stock 900 $7.10 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2023.
F2 25% of the original number of shares subject to the option vested on December 12, 2020, and 1/48th of the original number of shares subject to the option vested monthly thereafter.